Springworks Therapeutics: Strong Cash Position and Promising Drug Approval Outlook Justify Buy Rating
In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Springworks Therapeutics (SWTX – Research ...
Yahoo Finance20m
The development of novel drugs: the role of lyophilization
In 2022 alone, the US FDA approved 32 lyophilized drug products, of which oncology and infectious diseases represented 82% of ...
After decades, FDA finally moves to pull ineffective decongestant off shelves
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a ...
pharmaphorum2d
The evolving role of AI in drug submission and approval: An expert perspective
The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical development. The potential benefits are substantial, including faster ...
pharmaphorum1d
Unicycive eyes June FDA verdict for hyperphosphataemia drug
The FDA has started a review of Unicycive Therapeutics' drug for hyperphosphataemia in patients with chronic kidney disease ...
FierceBiotech8d
FDA delays decision on Merus' first-in-class cancer drug by 3 months
The FDA has scuttled Merus’ plans to win a speedy approval for i | The FDA has scuttled Merus’ plans to win a speedy approval ...
No, Trump’s drug program for terminal patients didn't save ‘thousands’ of lives
Medical experts who’ve studied the experimental treatment program, however, say there’s no evidence to support Trump’s claims ...
Medscape5d
Why a Failed Confirmatory Trial May Not Mean a Failed Drug
there are 64 oncology drug indications on the US market with accelerated approvals only. The FDA estimates the accelerated ...
BioPharma Dive2d
FDA approves new CAR-T competitor to Gilead’s Tecartus
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
SpringWorks Therapeutics Merits A Speculative Buy
An analysis of SpringWorks Therapeutics, Inc., including recent FDA approval, promising sales, and future funding for ...
FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...
Pharmaceutical Technology on MSN12d
US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle
The US District Court upholds the FDA’s approval of Avadel’s Lumryz, dismissing Jazz’s challenge over market exclusivity for ...